Crescent Capital Bdc (CCAP) closed at $10.38 on November 10, 2026, up 12.3% from the previous close, on volume of 522,154 shares (30-day average 217,376).
Data as of November 10, 2026.
Oppenheimer Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)
TipRanks (Wed, 11-Nov 8:25 AM ET)
KBW Remains a Hold on Crescent Capital BDC (CCAP)
TipRanks (Wed, 11-Nov 7:37 AM ET)
TipRanks (Wed, 11-Nov 5:30 AM ET)
Crescent Capital BDC declares $0.34/share & special dividend $0.03/share
Seeking Alpha News (Mon, 9-Nov 10:15 PM ET)
Crescent Capital BDC NII of $0.37 beats by $0.02
Seeking Alpha News (Mon, 9-Nov 4:28 PM ET)
Globe Newswire (Mon, 9-Nov 4:15 PM ET)
Here are the major earnings after the close Monday
Seeking Alpha News (Mon, 9-Nov 10:00 AM ET)
Crescent Capital BDC Q3 2026 Earnings Preview
Seeking Alpha News (Sun, 8-Nov 5:35 PM ET)
Seeking Alpha News (Sun, 8-Nov 10:00 AM ET)
Globe Newswire (Fri, 30-Oct 4:20 PM ET)
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Crescent Capital Bdc trades on the NASDAQ stock market under the symbol CCAP.
As of November 11, 2026, CCAP stock price declined to $10.34 with 269,034 million shares trading.
CCAP has a beta of 0.82, meaning it tends to be less sensitive to market movements. CCAP has a correlation of 0.12 to the broad based SPY ETF.
CCAP has a market cap of $380.99 million. This is considered a Small Cap stock.
Last quarter Crescent Capital Bdc reported $37 million in Revenue and $.37 earnings per share. This beat revenue expectation by $579,600 and exceeded earnings estimates by $.02.
In the last 3 years, CCAP traded as high as $20.19 and as low as $8.40.
The top ETF exchange traded funds that CCAP belongs to (by Net Assets): KBWD, VPC, MSSM.
CCAP has underperformed the market in the last year with a return of -14.1%, while the SPY ETF gained +12.9%. In the last 3 month period, CCAP fell short of the market, returning -8.0%, while SPY returned -1.2%. However, in the most recent 2 weeks CCAP has outperformed the stock market by returning +16.2%, while SPY returned -1.0%.
CCAP support price is $10.18 and resistance is $10.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCAP shares will trade within this expected range on the day.
